Related Experiment Video
Updated: Nov 30, 2025

Field Identification of Matricaria chamomilla using a Portable qPCR System
Published on: October 10, 2020
Herbal Medicine: Clinical Perspective and Regulatory Status
Md Abul Barkat1, Anjali Goyal2, Harshita A Barkat3
1Department of Pharmaceutics, College of Pharmacy, University of Hafr Al Batin, Al Jamiah, Hafr Al Batin 39524, Saudi Arabia.
Abstract:
Herbal medicines play an important role in treating various ailments due to their potentially high therapeutic values and acceptability by patients with different health complications. The practice of herbal medicine involves the use of a part of a plant, the entire plant, or a selective isolated phytoconstituent. The search for new drugs during the scientific era revived the interest in the discovery of herbal drugs from different natural resources. The present modern healthcare system involves the utilization of drugs and 50% of them are of natural origin. In recent years, there had been an upsurge in the interest for search of novel herbal drugs by the pharmaceutical industry. However, the discovery of such new novel phytomedicines involves various challenges in the identification of active constituents; their characterization, pharmacological activity, toxicity/adverse effects, drug interactions, and, most importantly, their regulatory requirements. The present review is mainly focused on the history of herbal medicine, current clinical perspective, and pharmaceutical and regulatory challenges facing herbal drugs. Moreover, problems encountered in drug discovery from herbal resources and their possible solutions have been delineated.
More Related Videos
07:16Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry
Published on: February 2, 2024
06:44Author Spotlight: Developing Identification Methods for Rhodiola crenulata and Investigating Its Resource Distribution and Pharmacological Effects
Published on: October 27, 2023
Related Concept Videos
Drug Regulation
Drug Classes and Categories
Drug Control Governance: Regulatory Bodies and Their Impact
Preclinical Development: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Dosage Regimen: Individualization